StocksFin Logo
BGNE logo
$BGNE

BeiGene, Ltd.

BGNE country of incorporation
|
https://www.beigene.com
|
Mr. John V. Oyler
|
9,000 employees
NASDAQ | Healthcare | Biotechnology
BGNE reported its Q322 earnings on November 9, 2022 (76 weeks ago).
$387.63M 87.8% vs. Q321 Revenues Q322
-29.74% 68.2% vs. Q321 Gross Profit Margin
-143.84% ! 28.3% vs. Q321 Net Profit Margin
-690.56M ! -22.7% vs. Q321 Free Cash Flow Q322
$-5.33 ! -20.6% vs. Q321 EPS Q322
Company Card Q322
As reported on November 9, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 9, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
387.63M
+13.5%
502.91M
-557.56M
+2.4%
$-5.33
Q22022
341.57M
+11.4%
449.38M
-571.45M
-31.6%
$-5.59
Q12022
306.63M
455.15M
-434.27M
$-4.29
FY2021
1.18B
 1.62B
-1.41B
$-10
Q42021
213.98M
+3.7%
479.03M
-585.65M
-41.5%
$-6.11
Q32021
206.44M
+37.6%
399.35M
-413.86M
+13.8%
$-4.42
Q22021
149.99M
-75.2%
392.35M
-480.34M
-822.4%
$-5.2
Q12021
605.87M
353.41M
66.5M
$0.73
FY2020
308.87M
 1.37B
-1.6B
$-10
FY2019
428.21M
 998.53M
-948.63M
$-10
FY2018
198.22M
 707.71M
-673.77M
$-10
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
6.73B
 2.07B
4.2B
710.58M
4.66B
Q22022
7.38B
 2.08B
4.53B
632.65M
5.3B
Q12022
8.02B
 2.14B
4.35B
671.88M
5.89B
FY2021
8.65B
 2.4B
4k
0
6.24B
FY2020
5.6B
 1.73B
1.38B
881.46M
3.87B
FY2019
1.61B
 633.93M
618.01M
262.32M
962.21M
FY2018
2.25B
 496.04M
712.94M
207.13M
1.74B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-561.91M
 169.48M
120.24M
-128.66M
-690.56M
-60.5%
Q22022
-379.96M
 658.71M
-17.58M
-50.29M
-430.25M
-20.6%
Q12022
-236.56M
 210.39M
-11.27M
-120.13M
-356.69M
FY2021
-1.3B
 640.66M
3.64B
0
-1.3B
FY2020
-1.28B
 -3.17B
5.2B
-229.03M
-1.51B
FY2019
-750.27M
 554.16M
85.68M
-158.61M
-908.88M
FY2018
-547.72M
 -637.61M
1.69B
-140.84M
-688.55M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees